FGF4 explained
Fibroblast growth factor 4 is a protein that in humans is encoded by the FGF4 gene.[1]
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene was identified by its oncogenic transforming activity. This gene and FGF3, another oncogenic growth factor, are located closely on chromosome 11. Co-amplification of both genes was found in various kinds of human tumors. Studies on the mouse homolog suggested a function in bone morphogenesis and limb development through the sonic hedgehog (SHH) signaling pathway.[2]
Function
During embryonic development, the 21-kD protein FGF4 acts as a signaling molecule critical for cell survival, proliferation, and patterning. It facilitates the survival and growth of the inner cell mass during the postimplantation phase by functioning as an autocrine or paracrine ligand.[3] [4] In the apical ectodermal ridge (AER), FGF4 plays a key role in initiating and sustaining limb bud outgrowth for both forelimbs and hindlimbs.[5] It also regulates limb digit number and programmed cell death in the interdigital mesenchyme.[6] Altered levels or regulation of FGF4 can lead to limb abnormalities such as postaxial polydactyly and cutaneous syndactyly, collectively known as polysyndactyly. In the absence of Fgf8, FGF4 is able to compensate by rescuing skeletal defects, indicating overlapping functions of FGF4 and FGF8 in limb skeleton patterning.[6] In zebrafish, FGF4 is required for establishing the correct left-right patterning of visceral organs such as the liver, pancreas, and heart. In this context, FGF4 functions independently of FGF8, highlighting their distinct roles in visceral organ development.[7]
Fgf signaling pathway has also been demonstrated to drive hindgut identity during gastrointestinal development, and the up regulation of the Fgf4 in pluripotent stem cell has been used to direct their differentiation for the generation of intestinal Organoids and tissues in vitro.[8]
Clinical significance
In canines, FGF4 retrogene insertions on chromosomes 12 and 18 have important clinical implications, particularly in relation to skeletal morphology and intervertebral disc disease (IVDD). These insertions are associated with disproportionate dwarfism characterized by shortened limbs and abnormal vertebral development.[9] [10]
The FGF4 retrogene on chromosome 12 is particularly associated with chondrodystrophy, a condition marked by shortened long bones, premature degeneration of intervertebral discs, and increased susceptibility to IVDD. These dogs often develop clinical symptoms such as spinal pain, limb weakness, and in severe cases, paralysis.
Meanwhile, the insertion on chromosome 18 contributes to a similar short-limbed phenotype but with variable impact on disc health. Recognition of these genetic variants has practical implications for veterinary care and breeding strategies, especially in predisposed breeds like Dachshunds, Corgis, and Basset Hounds.
Further reading
- Powers CJ, McLeskey SW, Wellstein A . Fibroblast growth factors, their receptors and signaling . Endocrine-Related Cancer . 7 . 3 . 165–197 . September 2000 . 11021964 . 10.1677/erc.0.0070165 . 10.1.1.323.4337 .
- Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T . cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity . Proceedings of the National Academy of Sciences of the United States of America . 84 . 9 . 2980–2984 . May 1987 . 2953031 . 304784 . 10.1073/pnas.84.9.2980 . free . 1987PNAS...84.2980T .
- Delli Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M, Basilico C . An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family . Cell . 50 . 5 . 729–737 . August 1987 . 2957062 . 10.1016/0092-8674(87)90331-X . 30018932 . free .
- Yoshida T, Miyagawa K, Odagiri H, Sakamoto H, Little PF, Terada M, Sugimura T . Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein . Proceedings of the National Academy of Sciences of the United States of America . 84 . 20 . 7305–7309 . October 1987 . 2959959 . 299281 . 10.1073/pnas.84.20.7305 . free . 1987PNAS...84.7305Y .
- Wada A, Sakamoto H, Katoh O, Yoshida T, Yokota J, Little PF, Sugimura T, Terada M . Two homologous oncogenes, HST1 and INT2, are closely located in human genome . Biochemical and Biophysical Research Communications . 157 . 2 . 828–835 . December 1988 . 2974287 . 10.1016/S0006-291X(88)80324-3 .
- Huebner K, Ferrari AC, Delli Bovi P, Croce CM, Basilico C . The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2 . Oncogene Research . 3 . 3 . 263–270 . 1989 . 3060803 .
- Adelaide J, Mattei MG, Marics I, Raybaud F, Planche J, De Lapeyriere O, Birnbaum D . Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma . Oncogene . 2 . 4 . 413–416 . April 1988 . 3283658 .
- Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M . Receptor specificity of the fibroblast growth factor family . The Journal of Biological Chemistry . 271 . 25 . 15292–15297 . June 1996 . 8663044 . 10.1074/jbc.271.25.15292 . free .
- Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J . Promotion of trophoblast stem cell proliferation by FGF4 . Science . 282 . 5396 . 2072–2075 . December 1998 . 9851926 . 10.1126/science.282.5396.2072 . 1998Sci...282.2072T .
- Helland R, Berglund GI, Otlewski J, Apostoluk W, Andersen OA, Willassen NP, Smalås AO . High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes . Acta Crystallographica. Section D, Biological Crystallography . 55 . Pt 1 . 139–148 . January 1999 . 10089404 . 10.1107/S090744499801052X . 1999AcCrD..55..139H .
- Bellosta P, Iwahori A, Plotnikov AN, Eliseenkova AV, Basilico C, Mohammadi M . Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis . Molecular and Cellular Biology . 21 . 17 . 5946–5957 . September 2001 . 11486033 . 87313 . 10.1128/MCB.21.17.5946-5957.2001 .
- Britto JA, Evans RD, Hayward RD, Jones BM . From genotype to phenotype: the differential expression of FGF, FGFR, and TGFbeta genes characterizes human cranioskeletal development and reflects clinical presentation in FGFR syndromes . Plastic and Reconstructive Surgery . 108 . 7 . 2026–39; discussion 2040–6 . December 2001 . 11743396 . 10.1097/00006534-200112000-00030 .
- Yamamoto H, Ochiya T, Tamamushi S, Toriyama-Baba H, Takahama Y, Hirai K, Sasaki H, Sakamoto H, Saito I, Iwamoto T, Kakizoe T, Terada M . HST-1/FGF-4 gene activation induces spermatogenesis and prevents adriamycin-induced testicular toxicity . Oncogene . 21 . 6 . 899–908 . January 2002 . 11840335 . 10.1038/sj.onc.1205135 . 12296298 .
- Sieuwerts AM, Martens JW, Dorssers LC, Klijn JG, Foekens JA . Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts . Thrombosis and Haemostasis . 87 . 4 . 674–683 . April 2002 . 12008951 . 10.1055/s-0037-1613065 . 13862591 .
- Koh KR, Ohta K, Nakamae H, Hino M, Yamane T, Takubo T, Tatsumi N . Differential effects of fibroblast growth factor-4, epidermal growth factor and transforming growth factor-beta1 on functional development of stromal layers in acute myeloid leukemia . Leukemia Research . 26 . 10 . 933–938 . October 2002 . 12163055 . 10.1016/S0145-2126(02)00033-4 .
- Lopez-Sanchez C, Climent V, Schoenwolf GC, Alvarez IS, Garcia-Martinez V . Induction of cardiogenesis by Hensen's node and fibroblast growth factors . Cell and Tissue Research . 309 . 2 . 237–249 . August 2002 . 12172783 . 10.1007/s00441-002-0567-2 . 11783465 .
- Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T . The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells . The Biochemical Journal . 375 . Pt 1 . 199–205 . October 2003 . 12841847 . 1223663 . 10.1042/BJ20030579 .
- Reményi A, Lins K, Nissen LJ, Reinbold R, Schöler HR, Wilmanns M . Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers . Genes & Development . 17 . 16 . 2048–2059 . August 2003 . 12923055 . 196258 . 10.1101/gad.269303 .
- Hirai K, Sasaki H, Yamamoto H, Sakamoto H, Kubota Y, Kakizoe T, Terada M, Ochiya T . HST-1/FGF-4 protects male germ cells from apoptosis under heat-stress condition . Experimental Cell Research . 294 . 1 . 77–85 . March 2004 . 14980503 . 10.1016/j.yexcr.2003.11.012 .
- Grigor'eva EV, Shevchenko AI, Mazurok NA, Elisaphenko EA, Zhelezova AI, Shilov AG, Dyban PA, Dyban AP, Noniashvili EM, Slobodyanyuk SY, Nesterova TB, Brockdorff N, Zakian SM . FGF4 independent derivation of trophoblast stem cells from the common vole . PLOS ONE . 4 . 9 . e7161 . September 2009 . 19777059 . 2744875 . 10.1371/journal.pone.0007161 . free . 2009PLoSO...4.7161G .
- Boulet AM, Capecchi MR . Signaling by FGF4 and FGF8 is required for axial elongation of the mouse embryo . Developmental Biology . 371 . 2 . 235–245 . November 2012 . 22954964 . 3481862 . 10.1016/j.ydbio.2012.08.017 .
Notes and References
- Galland F, Stefanova M, Lafage M, Birnbaum D . Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15----q23 . Cytogenetics and Cell Genetics . 60 . 2 . 114–116 . Jul 1992 . 1611909 . 10.1159/000133316 .
- Web site: Entrez Gene: FGF4 fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene).
- Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M . Requirement of FGF-4 for postimplantation mouse development . Science . 267 . 5195 . 246–249 . January 1995 . 7809630 . 10.1126/science.7809630 . 31312392 . 1995Sci...267..246F .
- Yuan H, Corbi N, Basilico C, Dailey L . Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3 . Genes & Development . 9 . 21 . 2635–2645 . November 1995 . 7590241 . 10.1101/gad.9.21.2635 . free .
- Boulet AM, Moon AM, Arenkiel BR, Capecchi MR . The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth . Developmental Biology . 273 . 2 . 361–372 . September 2004 . 15328019 . 10.1016/j.ydbio.2004.06.012 .
- Lu P, Minowada G, Martin GR . Increasing Fgf4 expression in the mouse limb bud causes polysyndactyly and rescues the skeletal defects that result from loss of Fgf8 function . Development . 133 . 1 . 33–42 . January 2006 . 16308330 . 10.1242/dev.02172 . free .
- Yamauchi H, Miyakawa N, Miyake A, Itoh N . Fgf4 is required for left-right patterning of visceral organs in zebrafish . Developmental Biology . 332 . 1 . 177–185 . August 2009 . 19481538 . 10.1016/j.ydbio.2009.05.568 .
- Lancaster MA, Knoblich JA . Organogenesis in a dish: modeling development and disease using organoid technologies . Science . 345 . 6194 . 1247125 . July 2014 . 25035496 . 10.1126/science.1247125 . 16105729 .
- Web site: Genetic Discovery Finds Dachshunds' Short-Leg Phenotype Linked To IVDD . 2022-04-13 . www.purinaproclub.com . en.
- Brown EA, Dickinson PJ, Mansour T, Sturges BK, Aguilar M, Young AE, Korff C, Lind J, Ettinger CL, Varon S, Pollard R, Brown CT, Raudsepp T, Bannasch DL . FGF4 retrogene on CFA12 is responsible for chondrodystrophy and intervertebral disc disease in dogs . Proceedings of the National Academy of Sciences of the United States of America . 114 . 43 . 11476–11481 . October 2017 . 29073074 . 5664524 . 10.1073/pnas.1709082114 . free . 2017PNAS..11411476B .